Dr Thomas Force, who teaches medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia, has revealed that the cancer-fighting drug, Gleevec can also be a cause of heart failure in leukemia patients under treatment.



Force
urged the doctors to be aware of the fact that Gleevec could effect the heart. Novartis, on the other hand, supported a detailed research on the matter.



Force
said that 10 patients taking Gleevec at the University of Texas’ M.D. Anderson Cancer Center have developed the symptoms of heart failure



The National Heart, Lung and Blood Institute, the Leukemia and Lymphoma Society, the Finnish Heart Foundation and the Paavo Nurmi Foundation supported the research.



Via: USNews



Read More..